⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BFRI News
Biofrontera Inc. Common Stock
Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
globenewswire.com
BFRI
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
globenewswire.com
BFRI
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
globenewswire.com
BFRI
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
globenewswire.com
BFRI
BFRIW
Form 8-K
sec.gov
BFRI
BFRIW
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
globenewswire.com
BFRI
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
globenewswire.com
BFRI